4 oaro - ich dive inside stability iceberg
TRANSCRIPT
![Page 1: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/1.jpg)
Dive Inside the Stability IcebergRegulatory & Scientific Affairs of
Harmonized Guidance
Obaid AliCivil Service Officer, Member, ISPE, PDA
26 March 2017
![Page 2: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/2.jpg)
Not the view of DRAP
Current judgment
No obligation on DRAP
Regulatory experience
D
I
S
C
L
A
I
M
E
R
References US-FDA WHO ICH NRAs
![Page 3: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/3.jpg)
What's the harm to give shelf life
without stability study while we have
experience of innovator drugs and
manufacturing of other drugs?
![Page 4: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/4.jpg)
Duration
Conditions
Safety
Efficacy
Quality
![Page 5: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/5.jpg)
How the quality varies with time
under the influence of conditions
(temperature, humidity, light)
![Page 6: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/6.jpg)
DSDP
Selection Container Closure Specification Testing Frequency
Storage Conditions
Commitment Evaluation Claim
Stress Photo
![Page 7: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/7.jpg)
DS
• 3 Primary Batches of pilot scale
• Same synthetic route
DP
• 3 Primary Batches, two, of pilot scale, one may be smaller
• Same formulation & CC
Batch Selection
![Page 8: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/8.jpg)
DS
• Packaging may be simulated
DP
• No, should be identical
Container Closure
![Page 9: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/9.jpg)
DS
• Physical, Chemical & Microbiological tests
DP
• + Preservative, Functionality Tests
Specifications
![Page 10: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/10.jpg)
Should Content Uniformity be done in
Stability Study?
![Page 11: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/11.jpg)
Should Sterility Test be done in
Injectable dosage forms?
![Page 12: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/12.jpg)
Should Dissolution be done as a Drug
Delivery Performance Test?
![Page 13: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/13.jpg)
Specifications
Finished Pharmaceutical Product
Specifications special for FDCs
![Page 14: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/14.jpg)
Remember
Degradation products must be calculated in % with reference
to the parent API, not the sum of APIs,
For
FDCs
![Page 15: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/15.jpg)
Rifampicin / isoniazidtablets
• Rifampicin quinone(degradant) as % of rifampicin
Lamivudine + Stavudine + Nevirapine
tablets
• Thymine (degradant) as % of stavudine
Example
![Page 16: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/16.jpg)
Remember
If 2 APIs react with each other, then the degradant to be
stated with respect to worst case
![Page 17: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/17.jpg)
Rifampicin / isoniazid tablets
• Isonicotinyl hydrazone forms from the 2 APIs.
• Specification: % hydrazonewith respect to rifampicin(worst-case in mass balance)
Example
![Page 18: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/18.jpg)
Remember
Unknown degradants – with respect to worst case
![Page 19: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/19.jpg)
Testing Frequency
For API with proposed re-test
period/shelf-life of at least 12
months
Every 3 months over first year,
every 6 months over next 12
months and annually
thereafter.
DS
DP
![Page 20: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/20.jpg)
Testing Frequency
Accelerated condition
Minimum of 3 time
points, including initial
and final time points
(e.g. 0, 3 & 6 months)
DS
DP
![Page 21: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/21.jpg)
Testing Frequency
Intermediate condition (due to
significant change under
accelerated condition)
Study design should include 4
time points (e.g. 0, 6, 9 and 12
months
DS
DP
![Page 22: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/22.jpg)
DS
• Bracketing, Matrixing not applicable
DP
• Bracketing, MatrixingApplicable
Testing Frequency
![Page 23: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/23.jpg)
Storage Conditions
Accelerated40⁰C+2⁰C
75% +5%RH6 months
1 of 3
DS
DP
![Page 24: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/24.jpg)
Storage Conditions
Long term
25⁰C+2⁰C 60%+5%RH or
30⁰C+2⁰C
65% +5%RH
12 months
2 of 3
DS
DP
![Page 25: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/25.jpg)
Storage Conditions
Intermediate30⁰C+2⁰C
65% +5%RH6 months
3 of 3
DS
DP
![Page 26: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/26.jpg)
Storage in a Refrigerator
Accelerated25⁰C + 2⁰C
60% + 5% RH6 months
DS
DP
Long term 5⁰C + 3⁰C 12 months
![Page 27: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/27.jpg)
Storage in a Freezer DS
DP
Long term- 20⁰C +
5⁰C12 months
Storage below - 20⁰C : Case by case basis
![Page 28: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/28.jpg)
Retest (DS)
• Compliance of attributes
• Suitability of use
Expiry (DP/DS)
• Expected within compliance
• No retesting
![Page 29: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/29.jpg)
Stress (DS)
Shocks exposure
Intrinsic stability
PD
Stress (DP)
Photosensitivity
Specific products
QIB
![Page 30: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/30.jpg)
• Must be stability indicating e.g.
• Assay of API
• Determination of Degradants
• Determination of Preservatives
Analytical Methods
• May not be suitable (e.g. non-specific like titration) i.e. Non-specific
• May not exist for the particular purpose (e.g. degradants)
CompendialMethods
![Page 31: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/31.jpg)
Significant Change
Drug Substance
Failure to meet
specifications
>5% change in assay from the initial results
Any degradation product exceeding its acceptance
criterion
Failure to meet acceptance criteria for appearance,
physical attributes and functionality tests
Failure to meet acceptance criteria for pH
Failure to meet acceptance criteria for dissolution of 12
dosage units
![Page 32: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/32.jpg)
Pitfall/Downside
The assay value is still within the limits
but the change during stability is
more than 5.0%Example
Release assay limit: 95.0 –
105.0%
Stability assay limit: 92.5 –
105.0%
Release assay:101.0% (within
spec)
24-Month assay: 93.0% (within
spec)
Loss in potency: 8.0% !!This is a significant change !!
![Page 33: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/33.jpg)
Points to be noted
Manage knowledge from R&D to plan
stability study
Stress study for intrinsic behavior & real time for retest
![Page 34: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/34.jpg)
Review
Stability testing is an
essential part of the process
of ensuring that the patient
receives a product that
meets established standards
of safety, efficacy and
quality
![Page 35: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/35.jpg)
Review
Give attention to
analysis and
calculation of
degradation products
especially in FDCs
![Page 36: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/36.jpg)
Review
Adopt Science & Risk
based Approach
Map Product
Attributes for Stability
during Development
![Page 37: 4 OARO - ICH Dive Inside Stability Iceberg](https://reader031.vdocuments.pub/reader031/viewer/2022030308/58eca7b01a28ab505b8b45c9/html5/thumbnails/37.jpg)
Review
Sound planning and execution of stability studies are important:
•Valuable time may be lost if the data are insufficient
•Always include all attributes which may change with
time (e.g. water content, friability & tablet strength in the
case of uncoated tablets) – pay upfront and save later